Enregistrement - Lobbyistes salariés d'entreprises

Objets

• Commerce intérieur
• Commerce international
• Développement régional
• Emploi et formation
• Impôts et finances
• Industrie
• Institutions financières
• Marchés publics
• Propriété intellectuelle
• Questions constitutionnelles
• Questions touchant les consommateurs
• Relations internationales
• Santé
• Sciences et technologies
• Travail

Détails sur l'objet

Politique ou Programme

• Canada’s Access to Medicines Regime (CAMR), certified under the Patent Act, which allows developing countries to access drugs at a lower cost, with regard to ensuring that Intellectual Property rights and anti-diversion mechanisms continue to be respected.
• National Immunization Strategy. Advocacy to seek continued investment in vaccines funding and an overall strategy for prevention of disease in Canada.
• Patented Medicines Review Board (PMPRB), certified under the Patent Act and whose guidelines seek to ensure a balance between the prices set by manufacturers for patented medicines sold in Canada and the maintenance of an attractive environment for pharmaceutical research and development. Specifically with regard to ensuring that any actions and proposed changes by the PMPRB are consistent with the mandate assigned by Parliament.
• Science and Technology (S&T) Strategy: Mobilizing Science and Technology to Canada's Advantage. Advocacy for measures which will allow for commercialization in health care to occur and for Canada to remain competitive internationally on Intellectual Property and other fronts.
• The Common Drug Review (CDR) process for reviewing new drugs and providing listing recommendations to publicly funded drug benefit plans in Canada. Ensuring the access needs of Canadian patients are met by advocating on activities undertaken in the context of the CDR.
• The National Pharmaceutical Strategy (NPS) as agreed by First Ministers in 2004. Advocacy for ways to increase access to medicines and vaccines for Canadian patients.

Proposition législative, Projet de loi ou résolution

• Food and Drugs Act and Bill C-51: An Act to amend the Food and Drugs Act and to make consequential amendments to other Acts. Specifically, with respect to the renewal of the drug approval process. Advocacy to ensure that Canada's review and approval process is timely, safe, effective, competitive and consistent with other jurisdictions.

Règlement

• Patented Medicines (Notice of Compliance) Regulations which seek to balance the protection of Intellectual Property (IP) and patents with cost containment. Advocacy to ensure that IP rights are respected and internationally competitive in order to promote Research and Development.

Techniques de communication

• Communication écrite
• Communication orale
• Appel au grand public

Institutions gouvernementales

• Affaires autochtones et Développement du Nord Canada
• Affaires étrangères et Commerce international Canada (MAECIC)
• Agence canadienne de développement international (ACDI)
• Agence de la santé publique du Canada (ASPC)
• Agence de promotion économique du Canada atlantique (APECA)
• Bureau du Conseil privé (BCP)
• Bureau fédéral de développement régional (Québec) (BFDR[Q])
• Cabinet du Premier ministre (CPM)
• Conseil d'examen du prix des médicaments brevetés (CEPMB)
• Conseil de recherches en sciences naturelles et en génie (CRSNG)
• Conseil national de recherches (CNRC)
• Députés de la Chambre des communes
• Environnement Canada
• Finances Canada (FIN)
• Industrie Canada
• Partenariat technologie Canada (PTC)
• Revenu Canada (RC)
• Santé Canada (SC)
• Secrétariat du Conseil du Trésor du Canada (SCT)
• Travaux publics et Services gouvernementaux Canada
• Tribunal canadien du commerce extérieur (TCCE)
• Tribunal de la concurrence (TC)

Adresse :
7333 Mississauga Road
Mississauga, ON  L5N 6L4
Canada

Numéro de téléphone : 905-819-3000
Numéro de fax : 905-819-3099  

Renseignements sur la société mère